ATS
PJP icon

Ashton Thomas Securities’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Ashton Thomas Securities’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.71K Hold
55
– – ﹤0.01% 427
2025
Q4 		$5.75K Hold
55
– – ﹤0.01% 289
2025
Q3 		$5.09K Hold
55
– – ﹤0.01% 386
2025
Q2 		$4.39K Hold
55
– – ﹤0.01% 274
2025
Q1 		$4.76K Hold
55
– – ﹤0.01% 254
2024
Q4 		$4.54K Hold
55
– – ﹤0.01% 251
2024
Q3 		$4.78K Buy
+55
New +$4.71K ﹤0.01% 950

Other funds holding PJP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ashton Thomas Securities's PJP Position: Q1 2026 in Review

Ashton Thomas Securities held its Invesco Pharmaceuticals ETF (PJP) position steady in Q1 2026 at 55 shares worth $5.71K. The position accounts for ﹤0.01% of the portfolio, ranked #427.

Ashton Thomas Securities first reported a position in PJP in Q3 2024 and has held it in 7 quarters since. The position peaked at $5.75K in Q4 2025. 119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.

  • Ashton Thomas Securities held 55 shares of Invesco Pharmaceuticals ETF worth $5.71K as of Q1 2026.
  • Ashton Thomas Securities left its Invesco Pharmaceuticals ETF share count unchanged in Q1 2026.
  • Invesco Pharmaceuticals ETF made up ﹤0.01% of Ashton Thomas Securities's portfolio in Q1 2026, its #427 holding.
  • Ashton Thomas Securities first reported a position in Invesco Pharmaceuticals ETF in Q3 2024 and has held it in 7 quarters since.
  • Ashton Thomas Securities's Invesco Pharmaceuticals ETF position peaked at $5.75K in Q4 2025.
  • 119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.

Based on Ashton Thomas Securities's 13F filing for Q1 2026, filed 18 May 2026.